Alexis Catala1,2, Mars Stone3,4, Michael P Busch3,4, Angelo D'Alessandro1,2. 1. Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. 2. Program in Structural Biology and Biochemistry, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. 3. Vitalant Research Institute, San Francisco, California, USA. 4. Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
Abstract
BACKGROUND: Diseases caused by arthropod-borne viruses remain a burden to global health; in particular, Zika virus (ZIKV) has been reported in 87 countries and territories. In healthy blood donors, ZIKV RNA can be detected in red blood cells (RBCs) months after infection, clearance of detectable nucleic acid in plasma, and seroconversion. However, little information is available on the impact of ZIKV infection to metabolism. STUDY DESIGN AND METHODS: We applied mass spectrometry-based metabolomics and lipidomics approaches to investigate the impact of ZIKV infection on RBCs over the course of infection. ZIKV-infected blood donors (n = 25) were identified through molecular and serologic methods, which included nucleic acid amplification testing and real-time polymerase chain reaction (PCR) for detection of ZIKV RNA and enzyme-linked immunosorbent assay (ELISA) for detection of flavivirus-specific IgM and IgG. RESULTS: In ZIKV RNA-positive donors, we observed lower glucose and lactate levels, and higher levels of ribose phosphate, suggestive of the activation of the pentose phosphate pathway. The top pathways altered in RBCs from ZIKV-IgM-positive donors include amino acid metabolism and biosynthesis, fatty acid metabolism and biosynthesis, linoleic acid and arachidonate metabolism and glutathione metabolism. RBCs from ZIKV-infected donors had increased levels of early glycolytic metabolites, and higher levels of metabolites of the pentose phosphate pathway. Alterations in acyl-carnitine and fatty acid metabolism are consistent with impaired membrane lipid homeostasis in RBCs from ZIKV IgM positive donors. CONCLUSION: RBC from healthy blood donors who had been infected by ZIKV are characterized by long-lasting metabolic alterations even months after infection has resolved.
BACKGROUND: Diseases caused by arthropod-borne viruses remain a burden to global health; in particular, Zika virus (ZIKV) has been reported in 87 countries and territories. In healthy blood donors, ZIKV RNA can be detected in red blood cells (RBCs) months after infection, clearance of detectable nucleic acid in plasma, and seroconversion. However, little information is available on the impact of ZIKV infection to metabolism. STUDY DESIGN AND METHODS: We applied mass spectrometry-based metabolomics and lipidomics approaches to investigate the impact of ZIKV infection on RBCs over the course of infection. ZIKV-infected blood donors (n = 25) were identified through molecular and serologic methods, which included nucleic acid amplification testing and real-time polymerase chain reaction (PCR) for detection of ZIKV RNA and enzyme-linked immunosorbent assay (ELISA) for detection of flavivirus-specific IgM and IgG. RESULTS: In ZIKV RNA-positive donors, we observed lower glucose and lactate levels, and higher levels of ribose phosphate, suggestive of the activation of the pentose phosphate pathway. The top pathways altered in RBCs from ZIKV-IgM-positive donors include amino acid metabolism and biosynthesis, fatty acid metabolism and biosynthesis, linoleic acid and arachidonate metabolism and glutathione metabolism. RBCs from ZIKV-infected donors had increased levels of early glycolytic metabolites, and higher levels of metabolites of the pentose phosphate pathway. Alterations in acyl-carnitine and fatty acid metabolism are consistent with impaired membrane lipid homeostasis in RBCs from ZIKV IgM positive donors. CONCLUSION: RBC from healthy blood donors who had been infected by ZIKV are characterized by long-lasting metabolic alterations even months after infection has resolved.
Authors: Tamir Kanias; Marion C Lanteri; Grier P Page; Yuelong Guo; Stacy M Endres; Mars Stone; Sheila Keating; Alan E Mast; Ritchard G Cable; Darrell J Triulzi; Joseph E Kiss; Edward L Murphy; Steve Kleinman; Michael P Busch; Mark T Gladwin Journal: Blood Adv Date: 2017-06-27
Authors: Lyla A Youssef; Abdelhadi Rebbaa; Sergey Pampou; Stuart P Weisberg; Brent R Stockwell; Eldad A Hod; Steven L Spitalnik Journal: Blood Date: 2018-04-17 Impact factor: 22.113
Authors: Alex George; Suvarnamala Pushkaran; Diamantis G Konstantinidis; Sebastian Koochaki; Punam Malik; Narla Mohandas; Yi Zheng; Clinton H Joiner; Theodosia A Kalfa Journal: Blood Date: 2013-01-24 Impact factor: 22.113
Authors: Vassilis L Tzounakas; Anastasios G Kriebardis; Hara T Georgatzakou; Leontini E Foudoulaki-Paparizos; Monika Dzieciatkowska; Matthew J Wither; Travis Nemkov; Kirk C Hansen; Issidora S Papassideri; Angelo D'Alessandro; Marianna H Antonelou Journal: Free Radic Biol Med Date: 2016-04-14 Impact factor: 7.376
Authors: Mars Stone; Sonia Bakkour; Marion C Lanteri; Donald Brambilla; Graham Simmons; Roberta Bruhn; Zhanna Kaidarova; Tzong-Hae Lee; Jose Orlando Alsina; Phillip C Williamson; Susan A Galel; Lisa L Pate; Jeffrey M Linnen; Steve Kleinman; Michael P Busch Journal: Lancet Infect Dis Date: 2020-07-13 Impact factor: 25.071
Authors: Lorenzo Bertolone; Micaela Kalani Roy; Ariel M Hay; Evan J Morrison; Davide Stefanoni; Xiaoyun Fu; Tamir Kanias; Steve Kleinman; Larry J Dumont; Mars Stone; Travis Nemkov; Michael P Busch; James C Zimring; Angelo D'Alessandro Journal: Transfusion Date: 2020-04-27 Impact factor: 3.157
Authors: Tiffany Thomas; Francesca Cendali; Xiaoyun Fu; Fabia Gamboni; Evan J Morrison; Jonathan Beirne; Travis Nemkov; Marianna H Antonelou; Anastasios Kriebardis; Ian Welsby; Ariel Hay; Karolina H Dziewulska; Michael P Busch; Steven Kleinman; Paul W Buehler; Steven L Spitalnik; James C Zimring; Angelo D'Alessandro Journal: Transfusion Date: 2021-04-26 Impact factor: 3.337